Tff Net Tangible Assets from 2010 to 2024

TFFP Stock  USD 2.16  0.15  7.46%   
Tff Pharmaceuticals Net Tangible Assets yearly trend continues to be relatively stable with very little volatility. Net Tangible Assets are likely to grow to about 46.8 M this year. Net Tangible Assets is the total assets of Tff Pharmaceuticals minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. View All Fundamentals
 
Net Tangible Assets  
First Reported
2010-12-31
Previous Quarter
44.5 M
Current Value
46.8 M
Quarterly Volatility
20.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tff Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tff main balance sheet or income statement drivers, such as Selling General Administrative of 6.8 M, Research Development of 9.9 M or Total Operating Expenses of 16.6 M, as well as many exotic indicators such as Price To Sales Ratio of 13.72, Dividend Yield of 0.0 or PTB Ratio of 1.38. Tff financial statements analysis is a perfect complement when working with Tff Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Tff Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Tff Pharmaceuticals Technical models . Check out the analysis of Tff Pharmaceuticals Correlation against competitors.
To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.

Latest Tff Pharmaceuticals' Net Tangible Assets Growth Pattern

Below is the plot of the Net Tangible Assets of Tff Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Tff Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tff Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Net Tangible Assets10 Years Trend
Slightly volatile
   Net Tangible Assets   
       Timeline  

Tff Net Tangible Assets Regression Statistics

Arithmetic Mean15,364,077
Coefficient Of Variation132.50
Mean Deviation18,879,577
Median(10,977)
Standard Deviation20,356,972
Sample Variance414.4T
Range50M
R-Value0.87
Mean Square Error109.2T
R-Squared0.76
Significance0.000026
Slope3,956,139
Total Sum of Squares5801.7T

Tff Net Tangible Assets History

202446.8 M
202344.5 M
202138.7 M
202037.3 M
201927.6 M
2018-3.2 M
2017 -1833.0

About Tff Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Tff Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Tff Pharmaceuticals investors use historical funamental indicators, such as Tff Pharmaceuticals's Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Tff Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Tff Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Tff Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Tff Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Tff Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Tangible Assets44.5 M46.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Tff Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Tff Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Tff Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Tff Pharmaceuticals Stock:
Check out the analysis of Tff Pharmaceuticals Correlation against competitors.
To learn how to invest in Tff Stock, please use our How to Invest in Tff Pharmaceuticals guide.
Note that the Tff Pharmaceuticals information on this page should be used as a complementary analysis to other Tff Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Complementary Tools for Tff Stock analysis

When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Correlations
Find global opportunities by holding instruments from different markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Tff Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tff Pharmaceuticals. If investors know Tff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tff Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(11.85)
Revenue Per Share
0.409
Quarterly Revenue Growth
(0.63)
Return On Assets
(0.76)
Return On Equity
(1.31)
The market value of Tff Pharmaceuticals is measured differently than its book value, which is the value of Tff that is recorded on the company's balance sheet. Investors also form their own opinion of Tff Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Tff Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tff Pharmaceuticals' market value can be influenced by many factors that don't directly affect Tff Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tff Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tff Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tff Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.